Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of ranirestat (AS-3201) in diabetic sensorimotor polyneuropathy
jRCT2080220465Phase 2
- Sponsor
- Sumitomo Pharma
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic peripheral polyneuropathy (DPN) and type 2 diabetes mellitus (T2DM) comparing Ranirestat with Placebo (2 arms).
02
Drugs
ranirestat
03
Conditions
diabetic peripheral polyneuropathy (DPN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080220465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220465.